[Federal Register Volume 64, Number 11 (Tuesday, January 19, 1999)]
[Notices]
[Pages 2905-2906]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 99-1038]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
Arthritis Advisory Committee; Notice of Meeting
AGENCY: Food and Drug Administration, HHS.
ACTION: Notice.
-----------------------------------------------------------------------
[[Page 2906]]
This notice announces a forthcoming meeting of a public advisory
committee of the Food and Drug Administration (FDA). The meeting will
be open to the public.
Name of Committee: Arthritis Advisory Committee.
General Function of the Committee: To provide advice and
recommendations to the agency on FDA's regulatory issues.
Date and Time: The meeting will be held on February 23, 1999, 8
a.m. to 5 p.m.
Location: Holiday Inn, The Kennedy Ballroom, 8777 Georgia Ave.,
Silver Spring, MD.
Contact Person: Kathleen R. Reedy or LaNise S. Giles, Center for
Drug Evaluation and Research (HFD-21), Food and Drug Administration,
5600 Fishers Lane, Rockville, MD 20857, 301-827-7001, or FDA Advisory
Committee Information Line, 1-800-741-8138 (301-443-0572 in the
Washington, DC area), code 12532. Please call the Information Line for
up-to-date information on this meeting.
Agenda: The committee will discuss issues in the design and
assessment of clinical trials of drugs, biologics, and devices that are
being developed for treatment of systemic lupus erythematosus.
Procedure: Interested persons may present data, information, or
views, orally or in writing, on issues pending before the committee.
Written submissions may be made to the contact person by February 18,
1999. Oral presentations from the public will be scheduled between
approximately 10 a.m. and 10:30 a.m. and 2 p.m. and 2:30 p.m. Time
allotted for each presentation may be limited. Those desiring to make
formal oral presentations should notify the contact person before
February 18, 1999, and submit a brief statement of the general nature
of the evidence or arguments they wish to present, the names and
addresses of proposed participants, and an indication of the
approximate time requested to make their presentation.
Notice of this meeting is given under the Federal Advisory
Committee Act (5 U.S.C. app. 2).
Dated: December 28, 1998.
Michael A. Friedman,
Deputy Commissioner for Operations.
[FR Doc. 99-1038 Filed 1-15-99; 8:45 am]
BILLING CODE 4160-01-F
